Cycloserine Plus Ethionamide Plus Pyrazinamide in the Treatment of Patients Excreting Isoniazid-resistant Tubercle Bacilli following Previous Chemotherapy

Ramakrishnan, C V and Parthasarathy, R and Sambamoorthy, S and Somasundaram, P R and Subbammal, S (1976) Cycloserine Plus Ethionamide Plus Pyrazinamide in the Treatment of Patients Excreting Isoniazid-resistant Tubercle Bacilli following Previous Chemotherapy. Indian Journal of Medical Research, 64 (1). pp. 76-82. ISSN 0971-5916

PDF
197604.pdf - Published Version
Restricted to Registered users only
Download (40kB) | Request a copy

Official URL: http://www.icmr.nic.in/Publications/IJMR.html

Abstract

The results of treatment with a daily triple-drug regimen of cycloserine plus ethionamide plus pyrazinamide in 62 patients with chronic drug-resistant pulmonary tuberculosis are described. Of 51 patients who could be assessed, 37 (73 per cent) had a favourable bacteriological response at 1 year; 2 had a bacteriological relapse by 36 months. Drug toxicity requiring clinical action occurred in 22 (35 per cent) of the 62 patients. Ethionamide was the main drug accounting for toxicity and had to be terminated in 7 patients.

Item Type:	Article
Subjects:	Tuberculosis > Clinical Research
Divisions:	Clinical Research
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	23 Jul 2013 09:38
Last Modified:	10 Mar 2016 04:17
URI:	http://eprints.nirt.res.in/id/eprint/127

Actions (login required)

View Item